Related Experiment Video
Updated: Feb 4, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Prophylactic procedure tract radiotherapy for malignant pleural mesothelioma: A systematic review and meta-analysis
Sarah Bergamin1, Martin Tio2, Mark John Stevens1
1Northern Sydney Cancer Centre - Radiation Oncology Unit, Northern Sydney Cancer Centre, Level 1, Royal North Shore Hospital, Reserve Rd. St Leonards, NSW, 2065, Australia.
Background And Purpose:
Malignant pleural mesothelioma (MPM) is an aggressive cancer with a propensity for seeding procedure tracts, leading to symptomatic metastases. There is conflicting evidence on the value of prophylactic procedure tract radiotherapy in reducing tract metastases. We performed a systematic review and meta-analysis to estimate the benefit of radiotherapy in this setting.
Materials And Methods:
Electronic databases were searched to January 1, 2018 for prospective randomized control trials with prophylactic procedure tract radiotherapy as the intervention arm. Pooled odds ratios and 95% confidence intervals were calculated using a random effects model. Study heterogeneity was assessed using the I2 statistic, and publication bias was evaluated by funnel plot and Egger's regression model.
Results:
Five studies were included for meta-analysis. Prophylactic radiotherapy did not have a statistically significant reduction on the risk of procedure site recurrence, with a pooled relative risk of 0.69 (95% CI 0.33-1.43). There was moderate heterogeneity between trials. All trials were assessed as moderate or high risk of bias overall.
Conclusion:
This systematic review has confirmed that there is no role for prophylactic procedure tract radiotherapy in MPM. In the absence of effective prophylactic procedures, patients need to be monitored closely, and palliative interventions delivered in a timely manner to reduce morbidity associated with procedure tract metastases.
Insights
Prophylactic radiotherapy does not prevent procedure tract metastases in malignant pleural mesothelioma (MPM). Close patient monitoring and timely palliative care are recommended for managing symptomatic metastases.
Area of Science:
- Oncology
- Radiotherapy
- Mesothelioma Research
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer.
- MPM can spread through procedure tracts, causing symptomatic metastases.
- Evidence on prophylactic radiotherapy for preventing tract metastases is conflicting.
Purpose of the Study:
- To systematically review and meta-analyze randomized controlled trials.
- To estimate the benefit of prophylactic radiotherapy in reducing procedure tract metastases in MPM.
- To evaluate the role of radiotherapy in managing MPM complications.
Main Methods:
- Systematic review and meta-analysis of prospective randomized controlled trials.
- Searched electronic databases up to January 1, 2018.
- Calculated pooled odds ratios using a random effects model; assessed heterogeneity and publication bias.
Main Results:
- Included five studies in the meta-analysis.
- Prophylactic radiotherapy showed no statistically significant reduction in procedure site recurrence (pooled RR 0.69, 95% CI 0.33-1.43).
- Moderate heterogeneity and moderate to high risk of bias were noted across trials.
Conclusions:
- Prophylactic radiotherapy has no role in preventing procedure tract metastases in MPM.
- Effective prophylactic measures are lacking.
- Close patient monitoring and timely palliative interventions are crucial for managing tract metastases and associated morbidity.
More Related Videos
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...

